| RS1567114551 |
OCA2
|
Health Risk |
Pathogenic |
— |
| RS1567115738 |
SMAD6
|
Health Risk |
Pathogenic |
— |
| RS1567118987 |
FAH
|
Health Risk |
Pathogenic/Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS1567123492 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1567123622 |
FAH
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinemia type I, Tyrosinemia type I |
| RS1567124404 |
RLBP1
|
Health Risk |
Pathogenic |
Retinitis punctata albescens, Retinitis pigmentosa |
| RS1567127243 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1567128142 |
MAPK8IP3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without variable brain abnormalities, NEDBA |
| RS1567128655 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1567129475 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1567129567 |
NPRL3
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS1567129739 |
NPRL3
|
Health Risk |
Pathogenic |
— |
| RS1567131023 |
UBR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Johanson-Blizzard syndrome, Johanson-Blizzard syndrome |
| RS1567131767 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1567133726 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1567134495 |
NPRL3
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS1567135103 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1567135138 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1567136357 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1567138270 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1567138301 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1567138536 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1567138573 |
NR2F2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital heart defects, multiple types |
| RS1567139896 |
NPRL3
|
Health Risk |
Pathogenic/Likely pathogenic |
Epilepsy, familial focal |
| RS1567141162 |
CHD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1567142658 |
FANCI
|
Health Risk |
Likely pathogenic |
— |
| RS1567142752 |
NPRL3
|
Health Risk |
Pathogenic |
— |
| RS1567143705 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS1567144266 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS1567145638 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS1567146946 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1567148391 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1567148587 |
PKD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease, adult type |
| RS1567148835 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS1567149938 |
CHD2
|
Health Risk |
Pathogenic |
— |
| RS1567149943 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1567149946 |
CHD2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 94, Complex neurodevelopmental disorder |
| RS1567149962 |
CHD2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1567152003 |
NPRL3
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS1567152270 |
CHD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Developmental and epileptic encephalopathy 94 |
| RS1567153194 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS1567153758 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1567154939 |
PKD1-AS1;PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS1567154953 |
PKD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, adult type |
| RS1567155145 |
PKD1;PKD1-AS1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, Polycystic kidney disease |
| RS1567155179 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1567157447 |
PKD1;PKD1-AS1
|
Health Risk |
Likely pathogenic |
— |
| RS1567158538 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS1567159074 |
PKD1;PKD1-AS1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease, Polycystic kidney disease |
| RS1567159145 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1567159386 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS1567159623 |
PKD1
|
Health Risk |
Pathogenic |
PKD1-related disorder, PKD1-related disorder |
| RS1567159701 |
NR2E3
|
Health Risk |
Pathogenic |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |
| RS1567160054 |
PMM2
|
Health Risk |
Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS1567160201 |
NR2E3
|
Health Risk |
Likely pathogenic |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |
| RS1567160967 |
NR2E3
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 37, Enhanced S-cone syndrome |
| RS1567163204 |
HBA2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1567163701 |
CHD2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1567164013 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS1567164150 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1567165630 |
FANCI
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia |
| RS1567165997 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1567166045 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1567166544 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1567166655 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1567168441 |
OCA2
|
Health Risk |
Pathogenic |
— |
| RS1567169118 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS1567169638 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1567170994 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1567171059 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS1567171182 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS1567171493 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS1567173560 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS1567173924 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1567173968 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS1567174297 |
ALDH1A3
|
Health Risk |
Likely pathogenic |
Isolated anophthalmia-microphthalmia syndrome, Isolated anophthalmia-microphthalmia syndrome |
| RS1567174597 |
PIGQ
|
Health Risk |
Pathogenic |
Epilepsy, Epilepsy |
| RS1567174997 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1567175626 |
FANCI
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group I |
| RS1567176006 |
SLX4
|
Health Risk |
Likely pathogenic |
Glioblastoma multiforme, Glioblastoma multiforme |
| RS1567176190 |
MYO9A
|
Health Risk |
Conflicting classifications of pathogenicity |
Myasthenic syndrome, congenital |
| RS1567176750 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1567177198 |
STRA6
|
Health Risk |
Pathogenic |
Matthew-Wood syndrome, Matthew-Wood syndrome |
| RS1567177684 |
PKD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease, adult type |
| RS1567177760 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS1567177764 |
PKD1
|
Health Risk |
Likely pathogenic |
— |
| RS1567178000 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1567178071 |
SLX4
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group P, Fanconi anemia |
| RS1567179036 |
FANCI
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group I |
| RS1567180636 |
PKD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease, adult type |
| RS1567180640 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1567182193 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS1567183122 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1567183633 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS1567183784 |
PKD1
|
Health Risk |
Pathogenic |
— |
| RS1567184117 |
POLG
|
Health Risk |
Likely pathogenic |
Progressive sclerosing poliodystrophy, Mitochondrial disease |
| RS1567184366 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1567185026 |
POLG
|
Health Risk |
Pathogenic |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1567185048 |
POLG
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive sclerosing poliodystrophy, Mitochondrial DNA depletion syndrome 4b |
| RS1567185138 |
PKD1
|
Health Risk |
Pathogenic |
— |